Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Am Acad Audiol. 2017 Oct;28(9):786–798. doi: 10.3766/jaaa.16144

Table 1.

Demographic information for study participants. L, left; R, right; IS, initial stimulation; CI, cochlear implant; HL, hearing loss.

Subject Internal Device Ear Dur. Deafness (yrs, mos) Age at IS (yrs, mos) Dur. CI Use (yrs, mos) Etiology, Onset
F1 24RE(CA) L 11,3 60,7 10,2 Unknown/Progressive
F2 24RE(CA) R 10,6 60,3 9,0 Unknown/Progressive
F5 24RE(CA) R 7,7 48,3 7,11 Unknown/Sudden from established HL
F10 24RE(CA) R 1,10 1,10 10,7 Waardenburg Syndrome/Congenital
F11 24RE(CA) L 8,3 8,3 17,0 Waardenburg Syndrome/Congenital
F17 24RE(CA) R 11,0 42,11 10,4 Congenital/Progressive
F27 24RE(CA) L 10,5 56,2 2,0 Otosclerosis/Progressive
N7 CI512 R 10,11 69,9 5,8 Unknown/Progressive
N11 CI512 L 6,0 67,5 5,0 Unknown-Familial & Noise Exposure/Progressive
N23 CI512 R 1,10 70,5 2,7 Menieres
FS22 CI422 L 2,3 13,9 3,2 Meningitis/Progressive
FS28 CI422 R 3,8 72,6 1,10 Unknown/Progressive
FS31 CI422 R 30 76,4 1,3 Noise Induced/Hereditary
FS32 CI422 L 8,4 58,9 3,2 Unknown/Hereditary & Progressive
FS33 CI422 R 0* 12,0 1,11 Auditory Neuropathy Spectrum Disorder/Congenital
NS20 CI522 R 28,9 31,9 0,8 Illness/Unknown
*

Participant had mild-moderate hearing loss.